ClinicalTrials.gg
Sign In
RecruitingNCT07875452Updated Oct 15, 2026

Virtual Reality Combined With Active Mobilization Post Flexor Tendon Repair

An interventional study of active mobilization and active mobilization plus IVR-based rehabilitation. in Flexor Tendon Injury, sponsored by Cairo University. Recruiting at 2 sites in Egypt. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled May 2026, registered Oct 2026).
  • Started May 2026; still recruiting 5 months later.
Updated Oct 15, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the efficacy of combining IVR-based rehabilitation with a controlled early active mobilization protocol on functional outcomes, digit range of motion, grip strength, pinch strength and pain following flexor tendon repair.

02

Conditions studied

  • Flexor Tendon Injury
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,909 studies on the registry; 1,445 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Browse Cairo University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing hand flexor tendon repair (within 24 hours up to 10 days) from both sexes.
  • Age ranges from 18 to 50 years
  • Only patients with isolated injuries to the flexor digitorum profundus and/or superficialis tendons will be selected
  • Ability to follow instructions and participate in rehabilitation sessions

Exclusion criteria

Exclusion Criteria:

  • Patients with associated injuries (fractures, skin loss, crush injury, thumb flexor tendon injuries, nerve injuries and vascular injuries) or systemic conditions (rheumatoid arthritis and diabetes) will be excluded
  • Previous trauma or surgery to the affected hand.
  • Cognitive impairments interfere with participation .
  • Participation in other rehabilitation programs.
  • Bilateral hand injuries
  • Delayed surgery after injury.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
54 participants (estimated)

Study arms

  • Active comparator
    Active mobilization group

    Behavioral: active mobilization

  • Experimental
    Combined treatment group

    Combination Product: active mobilization plus IVR-based rehabilitation.

Interventions

  • Behavioralactive mobilization

    controlled early active mobilization

  • Combination productactive mobilization plus IVR-based rehabilitation.

    controlled early active mobilization protocol plus IVR-based rehabilitation.

06

What researchers measure

Primary outcomes

  1. pinch strength(pinch gauge kg)

    Time frame: 8 weeks and 12 weeks after surgery

Other outcomes

  1. pain(visual analog scale)

    Time frame: baseline (day1),4 weeks,8weeks,and12weeks after surgery

  2. digit range of motion (total active motion)

    Time frame: 4 weeks,8weeks,and 12weeks after surgery

  3. grip strength(hand held dynamometer kg)

    Time frame: 8 weeks,12 weeks after surgery

  4. function(quick DASH)

    Time frame: baseline (day 1),4weeks,8weeks,and 12weeks after surgery

07

Study locations

2 of 2 sites recruiting
  • Sahel Teaching Hospital
    Cairo, Cairo Governorate 11697, Egypt
    Recruiting
  • Sahel Teaching Hospital
    Cairo, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2026 (actual). Primary completion is estimated for Apr 2027, 11 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 4, 2026
First posted
Oct 15, 2026
StartActual
May 12, 2026
Primary completionEst.
Apr 2027
CompletionEst.
Apr 2028
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07875452
Lead sponsor
Cairo University
Responsible party
Warda Ali El Sayed (assistant lecturer, Cairo University) — Principal investigator
First posted
Oct 15, 2026
Start date
May 12, 2026
Primary completion
Apr 2027 (estimated)
Completion
Apr 2028 (estimated)
Last update
Oct 15, 2026

Study contacts

Warda Ali
Contact
awarda560@gmail.com
01018045663

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Cairo University →

Start the discussion